Intarcia Therapeutics Company
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Investors
Connections from
Industry:
Genomic and Epigenominc Instabillity
Technology:
Immunotherapy
Estimated Revenue:
$10M to $50M
Headquarters:
United States
Employee Number:
251-500
Founded Date:
1997